Literature DB >> 10755394

Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model.

B Chen1, P A de Witte.   

Abstract

The phototherapeutic properties and tissue distribution of hypericin were investigated in DBA/2 mice bearing subcutaneously transplanted P388 lymphoma cells. The efficacy of the photodynamic therapy (PDT) 2 h after administration of hypericin (2, 5, or 20 mg/kg, i.p., 120 J/cm2, 595 nm) was substantially greater than the efficacy after a 24 h interval. PDT with Photofrin (5 mg/kg, i.p., 24-h interval, 120 J/cm2, 630 nm) showed no significant antitumoral effect. The hypericin uptake in some tissues was measured after administration of hypericin (5 or 20 mg/kg, i.p.) up to 168 h. A comparison of the distribution data and the PDT efficacy at various intervals suggests that the plasma concentration of hypericin, and to a lesser extent the tumor uptake, determines the tumor response to PDT with hypericin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10755394     DOI: 10.1016/s0304-3835(99)00381-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Photodynamic efficacy of hypericin targeted by two delivery techniques to hepatocellular carcinoma cells.

Authors:  Maha Fadel; Kawser Kassab; Tareq Youssef
Journal:  Lasers Med Sci       Date:  2010-09       Impact factor: 3.161

2. 

Authors:  C S Betz; A Leunig
Journal:  HNO       Date:  2003-12       Impact factor: 1.284

3.  Successful in vivo tumor visualization using fluorescence laparoscopy in a mouse model of disseminated alveolar rhabdomyosarcoma.

Authors:  Cristian Urla; Sorin Armeanu-Ebinger; Jörg Fuchs; Guido Seitz
Journal:  Surg Endosc       Date:  2014-08-23       Impact factor: 4.584

4.  Biliary and duodenal drainage for reducing the radiotoxic risk of antineoplastic 131I-hypericin in rat models.

Authors:  Yue Li; Cuihua Jiang; Xiao Jiang; Ziping Sun; Marlein Miranda Cona; Wei Liu; Jian Zhang; Yicheng Ni
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-07

5.  Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor model.

Authors:  Chad D Cole; James K Liu; Xiaoming Sheng; Steven S Chin; Meic H Schmidt; Martin H Weiss; William T Couldwell
Journal:  J Neurooncol       Date:  2008-01-29       Impact factor: 4.130

6.  Elucidation of the tumoritropic principle of hypericin.

Authors:  M Van de Putte; T Roskams; J R Vandenheede; P Agostinis; P A M de Witte
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

7.  Photoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio.

Authors:  Jingwen Yi; Xiaoguang Yang; Lihua Zheng; Guang Yang; Luguo Sun; Yongli Bao; Yin Wu; Yanxin Huang; Chunlei Yu; Shao-Nian Yang; Yuxin Li
Journal:  Biosci Rep       Date:  2015-04-20       Impact factor: 3.840

8.  Photodynamic effect of hypericin on the conformation and catalytic activity of hemoglobin.

Authors:  Jing Zhao; Wenying Meng; Peng Miao; Zhiguo Yu; Genxi Li
Journal:  Int J Mol Sci       Date:  2008-02-05       Impact factor: 6.208

9.  In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.

Authors:  Rainer Ritz; Christian Scheidle; Susan Noell; Florian Roser; Martin Schenk; Klaus Dietz; Wolfgang S L Strauss
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

Review 10.  Hypericin in the Light and in the Dark: Two Sides of the Same Coin.

Authors:  Zuzana Jendželovská; Rastislav Jendželovský; Barbora Kuchárová; Peter Fedoročko
Journal:  Front Plant Sci       Date:  2016-05-06       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.